# Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

> **NCT00254774** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 44 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** quetiapine fumarate or valproate

## Key facts

- **NCT ID:** NCT00254774
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2007-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254774, "Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00254774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*